digestive/alimentary system
N |
• normal colon length and intestinal histology
• no diarrhea
• normal intestinal basal cell proliferation
• no intestinal inflammation
• normal desmosomal plaques in intestines
|
• wider intercellular spaces between desmosomal plaques in small and large intestine
• normal desmosomal plaques in intestines
|
• stronger inflammatory reaction, hyperproliferation and increased epithelial detachment and crypt elongation in intestines and higher fecal bacterial colony forming unit (CFU) count after Citrobacter rodentium exposure
• normal infection clearance after Citrobacter rodentium exposure
|
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)
|
immune system
• stronger inflammatory reaction, hyperproliferation and increased epithelial detachment and crypt elongation in intestines and higher fecal bacterial colony forming unit (CFU) count after Citrobacter rodentium exposure
• normal infection clearance after Citrobacter rodentium exposure
|
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)
|
growth/size/body
N |
• normal postnatal weight gain and colon length
|
mortality/aging
• shorter colon, more profound weight loss, intestinal lesions and bloody diarrhea after administration of low doses of dextran sodium sulfate (DSS)
• epithelial loss, edema, inflammatory reactions and goblet cell loss in intestines after administration of low doses of dextran sodium sulfate (DSS)
|